Literature DB >> 995295

[Bile composition in patients with high risk of cholelithiasis].

M Ponz De Leon, R Ferenderes, N Carulli.   

Abstract

Clinical and epidemiological experience has shown that some subjects, such as diabetics and cirrhotics, are particularly prone to cholelithiasis. The cause of this association was sought, with particular reference to the biliary lipid pattern, since this was considered as a pathogenetic factor in high-risk patients of this kind. It was found that diabetics, like subjects with biliary lithiasis, have a high biliary cholesterol saturation index; this was not the case in cirrhosis. This increase was apparently due both to a fall in bile acids and an increase in bile cholesterol. On the other hand, no significant difference was found between diabetics and controls as far as the pool of bile acids was concerned. No important differences in bile acid pattern were noted. Deoxycolate tended to increase in subjects with cholelithiasis and fall (along with lithocolate) in those with cirrhosis. These findings were, however, devoid of statistical significance. The high incidence of cholelithiasis in diabetics is physiopathologically confirmed by significant "lithogenic" changes in bule lipid composition, whereas the high incidence in cirrhosis is not open to this explanation and probably rests on a different pathogenetic basis. The importance of bile saturation is clear, however, together with its therapeutic and prophylatic implications (chenodeoxycholic acid). The possible influence of unknown factors cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 995295

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  4 in total

1.  Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.

Authors:  Hani Al-Salami; Grant Butt; Ian Tucker; Svetlana Golocorbin-Kon; Momir Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-08-28       Impact factor: 2.441

2.  Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.

Authors:  J H Iser; P N Maton; G M Murphy; R H Dowling
Journal:  Br Med J       Date:  1978-06-10

3.  Bile lipid composition and bile acid pool size in diabetes.

Authors:  M P de Leon; R Ferenderes; N Carulli
Journal:  Am J Dig Dis       Date:  1978-08

4.  Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study.

Authors:  Lih-Yu Chang; Chih-Hsin Lee; Chia-Hao Chang; Ming-Chia Lee; Meng-Rui Lee; Jann-Yuan Wang; Li-Na Lee
Journal:  BMC Infect Dis       Date:  2018-02-01       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.